Ayurvedic management of Systemic Lupus Erythematosus - A Single Case Study
Abstract
Systemic lupus erythematosus (SLE) is a chronic autoimmune inflammatory disease. SLE is the disease with unknown etiology in which organs and cells undergo damage initially mediated by tissue-binding autoantibodies and immune complexes. In this paper, a patient diagnosed as SLE, which was managed successfully by Ayurveda treatment was discussed. A 39yr old female patient, visited OPD, with the complaints of rashes all over the body specially over the hands and legs and swelling all over the body specially on feet and hands and face since 6 years and mouth ulcers since 1 year. She was diagnosed as SLE from a higher medical centre with relevant investigations 6 years ago. And she was put on oral medications and steroids. As patient was not willing to continue with steroids any further, she alternatively opted for Ayurveda treatment. The condition was managed as per the principle of Vatarakta line of treatment. Manjishtadi Basti and other external therapy along with oral ulcer management have done for 15 days with oral medication prescribed during and after the treatment. The results of the treatment sustained almost for a year without any complications and flare up of symptoms.
Downloads
References
Harrison’s principle of Internal medicine edited by Antony S.Fausi, Dennis L. Kasper, Stephen L. Hauser, Dan L.Longo, J.larry jameson, Joseph Loscalzo, Volume 1, 20th edition, Page No-2516.
Harrison’s principle of Internal medicine edited by Antony S.Fausi, Dennis L. Kasper, Stephen L. Hauser, Dan L.Longo, J.larry jameson, Joseph Loscalzo, Volume 1, 20th edition, Page No-2518.
Agnivesha, Charaka Samhita, revised by Charaka and Dridabala with Ayurveda dipika commentary of Chakrapanidatta, edited by Yadavji Trikamji Acharya, Cikitsasthana 29/20, 9th edition, 2015, Varanasi: Chaukambha Sanskrit Sansthan; p.628.
Agnivesha, Charaka samhitha, revised by Charaka and Dridabala with Ayurveda dipika commentary of Chakrapanidatta, edited by Yadavji Trikamji Acharya, Cikitsasthana 29/21-23, 9th edition, 2015, Varanasi: Chaukambha Sanskrit sansthan; p.628.
Harrison’s principle of Internal medicine edited by Antony S.Fausi, Dennis L. Kasper, Stephen L. Hauser, Dan L.Longo, J.larry jameson, Joseph Loscalzo, Volume 1, 20th edition, Page No-2518-2521.
Agnivesha, Charaka samhitha, revised by Charaka and Dridabala with Ayurveda dipika commentary of Chakrapanidatta, edited by Yadavji Trikamji Acharya, Cikitsasthana 29/19, 9th edition, 2015, Varanasi: Chaukambha Sanskrit sansthan; p.628.
Agnivesha, Charaka samhitha, revised by Charaka and Dridabala with Ayurveda dipika commentary of Chakrapanidatta, edited by Yadavji Trikamji Acharya, Cikitsasthana 29/88, 9th edition, 2015, Varanasi: Chaukambha Sanskrit sansthan; p.631.
Agnivesha, Charaka samhitha, revised by Charaka and Dridabala with Ayurveda dipika commentary of Chakrapanidatta, edited by Yadavji Trikamji Acharya, Siddhisthana 10/21, 9th edition, 2015, Varanasi: Chaukambha Sanskrit sansthan; p.725.
Das Govind. Bhaishajya Ratnavali. Mishra S.N., editor. Ch. 29, Ver. 222-227. Varanasi: Chaukambha Surbharati Prakashan; 2013; p. 630.
Gupta et al. Pharmacological review of Brihat Saindhavadi Taila. International Journal of Information Research and Review, Vol. 05, Issue, 03, pp.5314-5316, March, 2018.
Das Govind. Bhaishajya Ratnavali. Mishra S.N., editor. Ch. 58, Ver. 20. Varanasi: Chaukambha Surbharati Prakashan; 2013; p. 937.
Copyright (c) 2022 Riddhi Sangani, Prajwal Narayan, Ganesh Puttur
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Journal of Ayurveda and Integrated Medical Sciences (JAIMS) retains the copyright of the contents of this journal but grant the readers the right to use the contents with terms and conditions under a creative common attribution licenses 4 of Attribution, Share Alike and Non-commercial type (CC BY-NC-SA) that allows copy, distribute, display, and perform the work and make derivative works based on it only for non-commercial purposes.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.